AI Generated Image
Joint-Pain Supplement Tied to Faster Alzheimer's Progression
Newser • • health
Key Points:
- University of Florida researchers found that glucosamine use is linked to a 25% increased risk of mild cognitive impairment progressing to Alzheimer's disease, based on patient data from 2012 to 2024.
- Among patients already diagnosed with Alzheimer's or related dementias, glucosamine use was associated with a 25% higher risk of death over time.
- The study, published in Nature Metabolism, does not prove causation but is supported by mouse experiments and brain tissue analyses suggesting glucosamine may exacerbate a metabolic process involved in Alzheimer's.
- Researchers highlight that these findings require confirmation through clinical trials before any changes to medical recommendations are made.
